Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
11/23/1994 | EP0625164A1 CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa |
11/23/1994 | EP0625163A1 Parathyroid hormone fragments, their preparation and medicaments containing the same |
11/23/1994 | EP0625162A1 Methods of producing analgesia and enhancing opiate analgesia |
11/23/1994 | EP0625161A1 Process for recovering a high-purity virus-inactivated factor viii by anion exchanger chromatography |
11/23/1994 | EP0625160A1 Leukinferon preparation |
11/23/1994 | EP0625159A1 Ikaros: a t cell pathway regulatory gene |
11/23/1994 | EP0625157A1 PLATELET GPIIIa P1?A1 AND P1?A2 EPITOPES, THEIR PREPARATION AND USE |
11/23/1994 | EP0625053A1 Urease-based vaccine against helicobacter infection |
11/23/1994 | EP0625052A1 Bacterial expression vectors containing dna encoding secretion signals of lipoproteins |
11/23/1994 | EP0625051A1 Hepatic growth factor receptor |
11/23/1994 | EP0625049A1 Ex vivo gene transfer |
11/23/1994 | EP0625048A1 Synthesis of human procollagens and collagens in recombinant dna systems |
11/23/1994 | EP0625047A1 Platelet transfusion |
11/23/1994 | EP0625043A1 Recombinant multivalent m protein vaccine |
11/23/1994 | EP0575522A4 Polypeptides derived from the human immunodeficiency virus endonuclease protein. |
11/23/1994 | EP0535088A4 Chimeric toxins with improved inter-domain geometry |
11/23/1994 | EP0531461B1 Biologically active peptides containing d-2-alkyltryptophan |
11/23/1994 | EP0464101B1 Improvements relating to the radio-labelling of proteins |
11/22/1994 | US5367065 Constitutive triple response gene and mutations |
11/22/1994 | US5367064 Proteins as enzyme inhibitors |
11/22/1994 | US5367063 Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis |
11/22/1994 | US5367060 Structure, production and use of heregulin |
11/22/1994 | US5367059 Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptor |
11/22/1994 | US5367057 Proteins and sequences for red blood cells |
11/22/1994 | US5367056 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs) |
11/22/1994 | US5367055 Process for treating zein containing material |
11/22/1994 | US5367053 Opioid peptide inhibitors |
11/22/1994 | US5367052 Amylin peptides |
11/22/1994 | US5366977 Method of treating cystic fibrosis using 8-cyclopentyl-1,3-dipropylxanthine or xanthine amino congeners |
11/22/1994 | US5366892 Gene encoding a coleopteran-active toxin |
11/22/1994 | US5366889 DNA encoding a protein-coupled receptor kinase |
11/22/1994 | US5366887 RI T-DNA promoters |
11/22/1994 | US5366883 Genetic engineering |
11/22/1994 | US5366876 Plasmid for the expression of hormone in escherichia |
11/22/1994 | US5366875 Methods for producing BMP-7 proteins |
11/22/1994 | US5366874 Molecular cloning and expression of biologically-active diphtheria toxin receptor |
11/22/1994 | US5366871 Ubiquitin-peptide extensions as enzyme substrates |
11/22/1994 | US5366866 Screening for cancer with antibodies |
11/22/1994 | US5366728 Vaccines for immunology of ruminants |
11/22/1994 | US5366440 Methods for treating disease states using oxidized lipoproteins in conjunction with chemotherapeutic effector agents |
11/22/1994 | EP0642666A4 Hepatitis c assay. |
11/22/1994 | CA1333162C Method for the expression of genes in yeast, and dna fragments as well as plasmids comprising said dna fragments to be used when carrying out the method |
11/22/1994 | CA1333151C Pharmaceutical compositions and use thereof in treating inflammation |
11/22/1994 | CA1333150C Method for the control of pneumocystis carinii |
11/20/1994 | CA2123865A1 Production for biologically active polypeptide |
11/19/1994 | CA2123669A1 Photoprotected bacillus thuringiensis toxin |
11/17/1994 | EP0624650A2 FemB gene of Staphylococcus epidermidis, FemB protein, and vectors and microorganisms comprising the FemB gen |
11/17/1994 | EP0624649A1 Polypeptide derived from a human glioblastoma cell line and DNA's encoding it |
11/17/1994 | EP0624648A1 Polypeptide derived form a human glioblastoma cell line and DNA's encoding it |
11/17/1994 | EP0624647A1 Polypeptide derived from a human gliobastoma cell line and DNAs encoding it |
11/17/1994 | EP0624646A1 Polypeptide derived from a human glioblastomer cell line and DNA's encoding it |
11/17/1994 | EP0624645A1 Human chondromodulin-I protein |
11/17/1994 | EP0624644A1 DNA fragment, vector containing the DNA fragment, transformant transformed with the vector and process for producing protein using the vector |
11/17/1994 | EP0624598A1 Hepatitis B-binding factor |
11/17/1994 | EP0624597A1 HCV peptides and uses thereof |
11/17/1994 | EP0624377A2 Lysosomal enzyme-cleavable antitumor drug conjugates |
11/17/1994 | EP0624376A1 Preparation and uses of LOS-depleted outer membrane proteins of gram-negative cocci |
11/17/1994 | EP0624201A1 Method for producing soluble t-receptors by co-transfection, and use of resulting products |
11/17/1994 | EP0624200A1 New polypeptides having granulocyte colony stimulating activity, preparation thereof and pharmaceutical compositions containing said polypeptides |
11/17/1994 | EP0624199A1 Methods for producing thrombin |
11/17/1994 | EP0624198A1 Synthetic peptides for a rubella vaccine |
11/17/1994 | EP0624197A1 Crystal proteins of bacillus thuringiensis, genes encoding them, and hosts expressing them |
11/17/1994 | EP0624196A1 Polypeptides with fibronectin binding sites as modulators for matrix assembly. |
11/17/1994 | EP0624195A1 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
11/17/1994 | EP0624194A1 Polypeptides derived from human aiv apolipoprotein, preparation and use thereof |
11/17/1994 | EP0624193A1 Aamp-1, a protein with local homologies to hiv-1 env and nef proteins |
11/17/1994 | EP0624192A1 Novel protein tyrosine kinases |
11/17/1994 | EP0624188A1 Novel adherent and invasive mycoplasma |
11/17/1994 | EP0624165A1 Large, latent complexes of tgf-beta2 and tgf-beta3 |
11/17/1994 | EP0624164A1 Peptides with organo-protective activity, process for their preparation and their use in the therapy |
11/17/1994 | EP0624163A1 Cyclic calcitonin derivatives and method for their production |
11/17/1994 | EP0624100A1 Dna encoding a human serotonin receptor (5-ht 4b?) and uses thereof |
11/17/1994 | EP0624099A1 Water soluble non-immunogenic polyamide cross-linking agents |
11/17/1994 | EP0624059A1 Combinatorial strategies for polymer synthesis |
11/17/1994 | EP0563280B1 Tissue plasminogen activator substitution variant |
11/17/1994 | EP0540676B1 Peptide compounds having growth hormone releasing activity |
11/17/1994 | EP0531448B1 Mammalian expression of the bmp-2 family |
11/17/1994 | EP0300033B1 Cytotoxic lymphocyte-specific protease-related molecules and methods |
11/17/1994 | EP0109441B1 Human-human hybridomas for neoplasms |
11/17/1994 | DE4416446A1 Sequences specific for human DNA |
11/16/1994 | CN1095106A Vaccines |
11/15/1994 | US5365015 Antisense constructs derived from pTOM13 plants and plant cells with reduced ethylene evolution |
11/15/1994 | US5364933 Methods of immunopurification of antigens of human immunodeficiency virus type 2 (HIV-2) |
11/15/1994 | US5364932 Pasteurizable, freeze-driable hemoglobin-based blood substitute |
11/15/1994 | US5364930 Synthetic C1q peptide fragments |
11/15/1994 | US5364851 Internal coupling/cyclization to form helical structures |
11/15/1994 | US5364842 Method of producing analgesia |
11/15/1994 | US5364841 Treatment of obesity and essential hypertension and related disorders |
11/15/1994 | US5364840 Synthetic calcitonin peptides |
11/15/1994 | US5364837 Follicle stimulating hormone for producing antibodies |
11/15/1994 | US5364791 Progesterone receptor having C. terminal hormone binding domain truncations |
11/15/1994 | US5364787 Genes and enzymes involved in the microbial degradation of pentachlorophenol |
11/15/1994 | US5364785 Incubation in serum-free medium |
11/15/1994 | US5364780 External regulation of gene expression by inducible promoters |
11/15/1994 | US5364779 Process for transforming cells |
11/15/1994 | US5364774 Isolation of polynucleotides like DNA, hybridization and degeneration |
11/15/1994 | US5364773 Vaccinia virus with deletions; safety |
11/15/1994 | US5364772 DNA molecule encoding the β3 -adrenergic receptor |
11/15/1994 | US5364771 Genetic engineering |
11/15/1994 | US5364769 Nucleic acid encoding neurotrophic factor four (NT-4), vectors, host cells and methods of production |